FDA To Finally Study Possible Increased Heart Risks Caused By Attention Deficit Medications
September 20th, 2007 Posted by: Dr. Cox
The Safety Profile Of Adderall, Concerta, Ritalin, Dexedrine And All Other ADHD / ADD Drugs Will Be Reviewed
(Posted by Tom Lamb at DrugInjuryWatch.com)
In a September 17, 2007 FDA News article titled “AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications” we learned that the safety of Adderall, Concerta, Ritalin, and Dexedrine — as well as all other attention deficit hyperactivity disorder (ADHD) and attention deficit disorder (ADD) drugs — will be finally be reviewed reviewed.
In more detail, the FDA will collaborate with the Agency for Men’s healthcare Research and Quality (AHRQ) to examine clinical data regarding 500,000 children and adults who have used ADHD / ADD drugs in the past to determine these drugs cause an increased risk of heart attacks, strokes, or other serious cardiovascular problems.